115 related articles for article (PubMed ID: 9618047)
1. Relations of nm23 expression to clinicopathologic variables and proliferative activity of gastric cancer lesions.
Nakamura T; Tabuchi Y; Ohno M
Cancer Detect Prev; 1998; 22(3):246-50. PubMed ID: 9618047
[TBL] [Abstract][Full Text] [Related]
2. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
4. Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.
Müller W; Schneiders A; Hommel G; Gabbert HE
Cancer; 1998 Dec; 83(12):2481-7. PubMed ID: 9874452
[TBL] [Abstract][Full Text] [Related]
5. Expression of nm23 gene in gastric cancer is associated with a poor 5-year survival.
Nesi G; Palli D; Pernice LM; Saieva C; Paglierani M; Kroning KC; Catarzi S; Rubio CA; Amorosi A
Anticancer Res; 2001; 21(5):3643-9. PubMed ID: 11848537
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
7. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Yagi H; Shirakawa R; Nagasaki M
Oncology; 1997; 54(6):482-9. PubMed ID: 9394845
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
Kim KM; Lee A; Chae HS; Shim SI
J Korean Med Sci; 1995 Dec; 10(6):406-13. PubMed ID: 8924224
[TBL] [Abstract][Full Text] [Related]
9. nm23 in the primary and metastatic sites of gastric carcinoma. Relation to AFP-producing carcinoma.
Kumar Dhar D; Kubota H; Tabara H; Kotoh T; Monden N; Igarashi M; Kohno H; Nagasue N
Oncology; 1999; 56(2):122-8. PubMed ID: 9949298
[TBL] [Abstract][Full Text] [Related]
10. Nm23 gene expression in gastric carcinoma: an immunohistochemical study.
Yeung P; Lee CS; Marr P; Sarris M; Fenton-Lee D
Aust N Z J Surg; 1998 Mar; 68(3):180-2. PubMed ID: 9563444
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical analysis of c-erB-2 and nm23 expression in early gastric carcinoma].
Aoyagi K; Koufuji K; Kodama I; Ohta J; Takamiya H; Mizutani K; Takeda J; Shirouzu K
Nihon Shokakibyo Gakkai Zasshi; 1996 Sep; 93(9):613-9. PubMed ID: 8965386
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
13. [A study on the relationship between clinicopathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53 and nm 23].
Shiroko T; Saji S; Kawaguchi Y; Kageyama T; Kunieda K; Umemoto T
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():118-23. PubMed ID: 7611773
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of CD44 and nm23 expression in patients with stage II and stage IIIA gastric carcinoma.
Yoo CH; Noh SH; Kim H; Lee HY; Min JS
J Surg Oncol; 1999 May; 71(1):22-8. PubMed ID: 10362087
[TBL] [Abstract][Full Text] [Related]
15. [Expression of nm23 in gastrointestinal smooth muscle tumors and its relation to cell proliferative activity].
Wang Q; Sun W; Zhao Y; Wang M; Qin Y; Fu Y
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):427-9. PubMed ID: 11825432
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of nm23 expression and chromosome 17 numerical aberrations in primary gastric cancer.
Terada R; Yasutake T; Nakamura S; Hisamatsu T; Sawai T; Yamaguchi H; Nakagoe T; Ayabe H; Tagawa Y
Med Oncol; 2002; 19(4):239-48. PubMed ID: 12512918
[TBL] [Abstract][Full Text] [Related]
17. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression.
Caligo MA; Cipollini G; Berti A; Viacava P; Collecchi P; Bevilacqua G
Int J Cancer; 1997 Feb; 74(1):102-11. PubMed ID: 9036878
[TBL] [Abstract][Full Text] [Related]
18. The significance of nm23 protein expression in human gastric carcinomas.
Ura H; Denno R; Hirata K
Surg Today; 1996; 26(12):957-65. PubMed ID: 9017955
[TBL] [Abstract][Full Text] [Related]
19. [Gastric cancer with P53 overexpression and nm23 low-expression has high potential for lymph node metastasis].
Zhang S; Ye S; Lin H
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):418-21. PubMed ID: 8697991
[TBL] [Abstract][Full Text] [Related]
20. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study.
Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
